Ceritinib/crizotinib/lorlatinibDrug resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1702卷 / 1期

关键词：

D O I：

10.1007/s40278-018-46183-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：73 / 73

相关论文

共 50 条

[21] Alectinib/ceritinib/crizotinibDevelopment of resistance and gastrointestinal toxicity: case report
Reactions Weekly, 2020, 1789 (1) : 19 - 19
[22] Catequentinib/ceritinib/crizotinibDrug resistance and lack of efficacy : case report
Reactions Weekly, 2023, 1938 (1) : 378 - 378
[23] CrizotinibALK mutations with acquired resistance to crizotinib: case report
Reactions Weekly, 2015, 1551 (1) : 89 - 89
[24] Crizotinib/selpercatinibDrug resistance and lack of response: case report
Reactions Weekly, 2022, 1918 (1) : 165 - 165
[25] Alectinib/crizotinib/lorlatinibAcquired drug resistance: case report
Reactions Weekly, 2024, 2026 (1) : 24 - 24
[26] Afatinib/crizotinib/erlotinibAcquired EGFR resistance: case report
Reactions Weekly, 2016, 1603 (1) : 15 - 15
[27] Brigatinib/crizotinib/lorlatinibAcquired drug resistance: case report
Reactions Weekly, 2023, 1963 (1) : 135 - 135
[28] Crizotinib/erlotinibDrug resistance, vomiting and rash: case report
Reactions Weekly, 2017, 1678 (1) : 66 - 66
[29] Crizotinib/icotinibDrug resistance and various toxicities: case report
Reactions Weekly, 2019, 1781 (1) : 122 - 122
[30] Crizotinib/gefitinib/osimertinibDrug resistance and rash: case report
Reactions Weekly, 2019, 1763 (1) : 117 - 117

← 1 2 3 4 5 →